Co‐based Nanozymatic Profiling: Advances Spanning Chemistry, Biomedical, and Environmental Sciences
J Li, X Cai, P Jiang, H Wang, S Zhang, T Sun… - Advanced …, 2024 - Wiley Online Library
Nanozymes, next‐generation enzyme‐mimicking nanomaterials, have entered an era of
rational design; among them, Co‐based nanozymes have emerged as captivating players …
rational design; among them, Co‐based nanozymes have emerged as captivating players …
The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease
The hypothesis that the small conducting airways were the major site of obstruction to airflow
in normal lungs was introduced by Rohrer in 1915 and prevailed until Weibel introduced a …
in normal lungs was introduced by Rohrer in 1915 and prevailed until Weibel introduced a …
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is
the fourth leading cause of chronic morbidity and mortality in the United States, and is …
the fourth leading cause of chronic morbidity and mortality in the United States, and is …
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations
A Papi, CM Bellettato, F Braccioni… - American journal of …, 2006 - atsjournals.org
Rationale: Severe exacerbations of chronic obstructive pulmonary disease (COPD) are
major causes of health care costs mostly related to hospitalization. The role of infections in …
major causes of health care costs mostly related to hospitalization. The role of infections in …
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease
S Sethi, N Evans, BJB Grant… - New England Journal of …, 2002 - Mass Medical Soc
Background The role of bacterial pathogens in acute exacerbations of chronic obstructive
pulmonary disease is controversial. In older studies, the rates of isolation of bacterial …
pulmonary disease is controversial. In older studies, the rates of isolation of bacterial …
COPD exacerbations: definitions and classifications
S Burge, JA Wedzicha - European Respiratory Journal, 2003 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is defined independently of exacerbations,
which are largely a feature of moderate-to-severe disease. This article is the result of a …
which are largely a feature of moderate-to-severe disease. This article is the result of a …
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
JA Wedzicha, PMA Calverley… - American journal of …, 2008 - atsjournals.org
Rationale: Exacerbations are key drivers of morbidity and mortality in chronic obstructive
pulmonary disease (COPD). Objectives: We compared the relative efficacy of the long-acting …
pulmonary disease (COPD). Objectives: We compared the relative efficacy of the long-acting …
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations
IS Patel, TAR Seemungal, M Wilks, SJ Lloyd-Owen… - Thorax, 2002 - thorax.bmj.com
Background: Patients with chronic obstructive pulmonary disease (COPD) are prone to
frequent exacerbations which are a significant cause of morbidity and mortality. Stable …
frequent exacerbations which are a significant cause of morbidity and mortality. Stable …
Impact of exacerbations on COPD
A Anzueto - European Respiratory Review, 2010 - Eur Respiratory Soc
Exacerbations of chronic obstructive pulmonary disease (COPD) determine disease-
associated morbidity, mortality, resource burden and healthcare costs. Acute exacerbation …
associated morbidity, mortality, resource burden and healthcare costs. Acute exacerbation …
Exacerbations of chronic obstructive pulmonary disease
Exacerbations of chronic obstructive pulmonary disease are of major importance in terms of
their prolonged detrimental effects on patients, the acceleration in disease progression and …
their prolonged detrimental effects on patients, the acceleration in disease progression and …